Skip Navigation


BJA Advance Access originally published online on June 25, 2004
British Journal of Anaesthesia 2004 93(3):408-413; doi:10.1093/bja/aeh216
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/3/408    most recent
aeh216v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Docquier, M.-A.
Right arrow Articles by De Kock, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Docquier, M.-A.
Right arrow Articles by De Kock, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2004

Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia

M.-A. Docquier, P. Lavand'homme, V. Boulanger, V. Collet and M. De Kock*

Department of Anaesthesiology, Laboratory of Anaesthesia, University of Louvain, St Luc Hospital, av. Hippocrate 10–1821, 1200 Brussels, Belgium

* Corresponding author. E-mail: dekock{at}anes.ucl.ac.be

Background. Opioid-induced hyperalgesia has been demonstrated in awake animals. We observed an increased haemodynamic reactivity in response to noxious stimuli in rats under sevoflurane anaesthesia treated with a very low dose of sufentanil. The aim of this investigation was to determine whether the two phenomena share a common origin: an opioid-induced excitatory reaction. To address this, we administered several drugs with proven efficacy in opioid hyperalgesia to rats presenting with haemodynamic hyper-reactivity.

Methods. The MACbar of sevoflurane was measured in controls and in animals treated with sufentanil 0.005 µg kg–1 min–1 before and after administration of i.v. (0.25, 0.5 mg kg–1) and intrathecal (i.t.) (250 µg) ketamine, i.v. (0.5, 1 mg kg–1) and i.t. (30 µg) MK-801(NMDA antagonist), i.v. (0.1, 0.5 mg kg–1) naloxone, i.v. (10 mg kg–1) and i.t. (50, 100 µg) ketorolac or i.t. (100, 150 µg) meloxicam (COX-2 inhibitor).

Results. Sufentanil 0.005 µg kg–1 min–1 significantly increased MACbar (3.2 (SD 0.3) versus 1.9 (0.3) vol%). With the exception of naloxone, all drugs displayed a significant MACbar-sparing effect (>50%) in controls. Naloxone completely prevented haemodynamic hyperactivity. Two patterns of reaction were recorded for the other drugs: either hyper-reactivity was suppressed and the MACbar-sparing effect was maintained (i.t. ketamine, i.t. MK-801, i.t. ketorolac [100 µg], i.t. meloxicam [150 µg]) or hyper-reactivity was blocked but MACbar-sparing effect was lost (i.v. ketamine [0.5 mg kg–1], i.v. MK-801 [0.5, 1 mg kg–1], i.v. ketorolac [10 µg kg–1], i.t. ketorolac [50 µg], i.t. meloxicam [100 µg]).

Conclusions. We have demonstrated that low-dose sufentanil-induced haemodynamic hyper-reactivity is an excitatory µ-opiate-related phenomenon. This effect is reversed by drugs effective in treating opiate-induced hyperalgesia.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
F. Aubrun, N. Valade, P. Coriat, and B. Riou
Predictive Factors of Severe Postoperative Pain in the Postanesthesia Care Unit
Anesth. Analg., May 1, 2008; 106(5): 1535 - 1541.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.